Zoromol-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory and analgesic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol provides effective analgesia and antipyretic action through central inhibition of prostaglandin synthesis, complementing the anti-inflammatory effects of Aceclofenac. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of inflammation and edema, enhancing tissue repair and reducing pain. This combination is indicated for the management of acute and chronic musculoskeletal disorders, postoperative pain, rheumatoid arthritis, osteoarthritis, and other inflammatory conditions where pain and swelling are prominent. Zoromol-SP offers rapid and sustained relief from pain and inflammation, improving patient mobility and quality of life. It should be used under medical supervision, with caution in patients with a history of gastrointestinal ulcers, bleeding disorders, or hepatic and renal impairment. Common adverse effects may include gastrointestinal discomfort, nausea, and hypersensitivity reactions. Regular monitoring is advised during prolonged therapy to ensure safety and efficacy.